In VitroActivity of 19 Antimicrobial Agents against Enterococci from Healthy Subjects and Hospitalized Patients and Use of anaceGene Probe fromEnterococcus faecalisfor Species Identification
- 1 March 2001
- journal article
- research article
- Published by Mary Ann Liebert Inc in Microbial Drug Resistance
- Vol. 7 (1) , 39-46
- https://doi.org/10.1089/107662901750152765
Abstract
We tested 165 enterococcal isolates, biased toward vancomycin resistant (VR) isolates, collected during recent years from fecal samples of healthy subjects and clinical specimens of hospitalized patients (mostly from United States and some from Europe) for susceptibility to 19 antimicrobials. Nosocomial isolates, whether VR or not, were more often highly resistant to aminoglycosides and clindamycin than fecal isolates from healthy community volunteers and more often resistant to erythromycin, chloramphenicol, trimethoprim, levofloxacin and, for E. faecium, ampicillin (93 vs. 0%). Resistance rates were similar between nosocomial and community-fecal isolates for minocycline, rifampin and quinupristin-dalfopristin (Q-D). None of the 165 enterococci tested hybridized with aph(2″)-Ic and aph(2″)-Id probes for recently described gentamicin resistance genes and 37 of the 39 isolates with high level resistance (HLR) to gentamicin hybridized with an intragenic aac(6′)-aph(2″) probe. Of the two newer drugs tested, daptomycin MIC90s were 0.25 µg/mL for E. faecalis and 1 µg/mL for E. faecium, regardless of their vancomycin resistance level or source. For Q-D, none of 28 E. faecium from community based healthy subjects in the USA and 7 of 66 E. faecium from hospitalized patients in the United States were resistant. Among these 7 Q-Dr United States isolates and 7 Q-Dr isolates from Europe (MICs of Q-D of 4-8 µg/mL), none hybridized with vat(D) (formerly satA) and vat(E) (formerly satG) DNA probes, indicating the involvement of other mechanism/s of resistance in these isolates. We also demonstrated that an intragenic probe of the gene ace from E. faecalis showed specific hybridizations to all E. faecalis isolates, suggesting the usefulness of this gene for identification of this species.Keywords
This publication has 29 references indexed in Scilit:
- In vivo testing of anEnterococcus faecalis efaAmutant and use ofefaAhomologs for species identificationFEMS Immunology & Medical Microbiology, 1998
- Influence of Oral Glycopeptides on the Fecal Flora of Human Volunteers: Selection of Highly Glycopeptide-Resistant EnterococciThe Journal of Infectious Diseases, 1996
- High-Level Resistance to Aminoglycosides: Comparison of Community and Nosocomial Fecal Isolates of EnterococciClinical Infectious Diseases, 1995
- In vitro activity of novobiocin against multiresistant strains of Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1993
- Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1993
- The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic optionsJournal of Antimicrobial Chemotherapy, 1991
- Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activityAntimicrobial Agents and Chemotherapy, 1989
- Should novobiocin be clinically re-evaluated?Diagnostic Microbiology and Infectious Disease, 1989
- In vitro activity of LY146032 against gram-positive bacteriaDiagnostic Microbiology and Infectious Disease, 1988
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. II. CHLORAMPHENICOL AND ITS METABOLIC PRODUCTS IN THE BLOOD OF PATIENTS WITH SEVERE RENAL DISEASE OR HEPATIC CIRRHOSIS*†Journal of Clinical Investigation, 1959